Cytek Biosciences Inc. logo

Cytek Biosciences Inc.

CTKB | NASDAQ
Chart Builder DCF Calculator
$5.28
-$0.02 (-0.38%)
At close: Sep 21, 2026, 4:00 PM ET
$5.48
+$0.20 (+3.79%)
Pre-market: Sep 22, 2026, 7:42 AM ET

Market Data

Market Cap
$681.87M
Enterprise Value
$446.33M
Beta
1.19
Average Volume
1.21M
Shares Outstanding (Diluted)
129.46M
Shares Change YoY
1.99%
Institutional Ownership
66.10%
Exchange
NASDAQ
ISIN
US23285D1090

Price Performance

Price Change 1M
9.1%
Price Change 3M
29.7%
Price Change 6M
14.8%
Price Change YTD
7.3%
Price Change 1Y
36.8%
Price Change 3Y
-17.2%
Price Change 5Y
-78.1%
1M CAGR (ann.)
25.7%
1Y CAGR (ann.)
29.1%
5Y CAGR (ann.)
-27.4%
All-Time CAGR
-21.8%

Valuation

PE Ratio
-8.52
Forward PE
N/A
PEG Ratio
0.06
Forward PEG
0.32
PS Ratio
3.30
Forward PS
3.10
PB Ratio
2.12
P/FCF Ratio
-40.15
P/Adj. FCF Ratio
-15.78
P/OCF Ratio
-105.60
EV/Sales
2.16
EV/EBIT
-11.43
EV/EBITDA
-14.81
EV/FCF
-26.28
Earnings Yield
-11.7%
FCF Yield
-2.5%
Adj. FCF Yield
-6.3%

Financial Health

Net Cash
$252.33M
Total Debt
$26.46M
Cash & Short-Term Investments
$262M
Total Assets
$446.93M
Current Ratio
4.48
Quick Ratio
3.86
Debt / Equity Ratio
0.08
Debt / EBITDA
-0.88
Debt / FCF
-1.56
OCF / Debt
-0.33
Interest Coverage
-25.34
Altman Z-Score
3.82
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
53.2%
Operating Profit Margin
-21.6%
EBITDA Margin
-13.1%
Net Profit Margin
-39.0%
FCF Margin
-8.2%
Adj. FCF Margin
-20.9%
SBC / Revenue
10.3%
SBC Impact (per share)
-154.4%

Returns

Return on Assets
-18.0%
Return on Equity
-23.5%
Return on Invested Capital
-11.9%
Return on Capital Employed
-12.3%
Return on Tangible Assets
-19.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
5.6%
Revenue CAGR 5Y
13.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-91.4%
EPS CAGR 5Y
-72.7%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-875.2%
FCF CAGR 5Y
19.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
29.0%
Revenue Growth Next 3Y
7.8%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.07
EPS Growth Est (next Q)
600.0%
Revenue Est (next Q)
$52.95M
Revenue Growth Est (next Q)
1.3%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$4.88
Price Target Upside
-7.6%

Cash Flow

Operating Cash Flow
$-8.77M
Free Cash Flow
$-16.98M
Adj. Free Cash Flow
$-43.21M
FCF Per Share
-$0.09
OCF Per Share
-$0.05
OCF/S Ratio
-2.9%

Income Statement

Revenue
$206.71M
Gross Profit
$110.03M
Operating Income
$-44.65M
EBITDA
$-30.14M
Net Income
$-80.58M
EPS (Diluted)
-$0.62
Revenue / Employee
$303.09K
Profit / Employee
$-118.15K
Employees
682

© 2026 bestshares.com. All rights reserved.